Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R. Bosse, John M. Maris, Daniel Martínez et al.|Cancer Cell|2017Cited by 229
Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk NeuroblastomaPresha Rajbhandari, Andrea Califano, Gonzalo López et al.|Cancer Discovery|2018Cited by 197